The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection.

MLA

Maan, Loveleen, et al. “The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection.” Cureus, vol. 15, no. 11, Nov. 2023, p. e49314. EBSCOhost, https://doi.org/10.7759/cureus.49314.

APA

Maan, L., Anand, N., Yadav, G., Mishra, M., & Gupta, M. K. (2023). The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection. Cureus, 15(11), e49314. https://doi.org/10.7759/cureus.49314

Chicago

Maan, Loveleen, Neelesh Anand, Ghanshyam Yadav, Manjaree Mishra, and Munesh K Gupta. 2023. “The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection.” Cureus 15 (11): e49314. doi:10.7759/cureus.49314.